Vogenx, Inc. share price logo

Vogenx, Inc.

NASDAQ: VOGX

Small Cap

$19.71

-0.21

(-1.05%)

Live

as on

Vogenx, Inc. Stock Performance

as on October 31, 2026 at 3:19 am IST

  • Day's Low

    Day's High

    $19.23
    $20.32
    downward going graph

    2.44%

    Downside

    3.09%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Vogenx, Inc. share price movements today

Previous Close
$19.92
Open
$19.85
Volume
65.1K
Market Cap
$281.1M
Day's Low - High
$19.23 - $20.32

Vogenx, Inc. Historical Returns

1 Month Return
-12.59 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Vogenx, Inc. Stock Fundamentals & Key Indicators

Check Vogenx, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$281.1M

EPS (TTM)

-0.69

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Vogenx, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vogenx, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$281.1MNANA0.00%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Analyst Recommendation on Vogenx, Inc. Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Vogenx, Inc.. Average target price of $42

Vogenx, Inc. Share Price Target

Get share price movements and forecasts by analysts on Vogenx, Inc..

Current Price

$19.71

Analyzed by

1 Analysts

High

$42

0

Low

$42

Vogenx, Inc. target price $0, a slight upside of 0% compared to current price of $19.71. According to 1 analysts rating.

Indian Investors' Interest in Vogenx, Inc. Stock

Search interest for Vogenx, Inc. Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-26% versus previous 30 day period

Vogenx, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2025
Jun 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
0
0
0
0
EBITDA
0
0
0
0
Interest Expense
-
-
-
-
Depreciation
-
-
-
-
Income Before Tax
0
0
0
0
Income Tax Expense
-
-
-
-
Net Income
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Vogenx, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-2
-1
EBITDA
-2
-1
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
-2
-1
Income Tax Expense
-
-
Net Income
-2
-1
Net Profit Margin
0.00%
0.00%

Vogenx, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2025
Mar 2026
Jun 2026
Net Income
0
0
0
Operating Cash Flow
0
0
0
Investing Cash Flow
-
-
-
Financing Cash Flow
-
-
-
Change in Cash
0
0
0

Vogenx, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-1
Operating Cash Flow
-1
Investing Cash Flow
-
Financing Cash Flow
0
Change in Cash
0

Global Institutional Holdings in Vogenx, Inc.

Check out the Institutions with significant holdings in Vogenx, Inc..

Funds
Holdings
Vanguard
0.52%

Vogenx, Inc. News & Key Events

  • img

    Today's Timeline - 09 October

    Fri, 05:30 PM

    -

    Vogenx appoints Richard Gorman as Chief Commercial Officer, effective October 12, 2026, resigning from the Board.

Insights on Vogenx, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, VOGX stock has moved up by 14.2%

About Vogenx, Inc.

Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.
OrganisationVogenx, Inc.
Headquarters3901 Barrett Drive, Suite 300, Raleigh, NC, 27609, US
IndustryBiotechnology
CEOJames Green

Key Management of Vogenx, Inc.

Name

Title

Mr. Steven R. Delmar

CFO, Corporate Secretary & Director

Dr. William Wilkison Ph.D.

Chief Scientific Officer, Chair of Scientific Advisory Board & Director

Mr. James Green

President, CEO & Chairman

FAQs

What is Vogenx, Inc. share price today?

Vogenx, Inc. share price today is $19.71 as on . Vogenx, Inc. share today touched a day high of $20.32 and a low of $19.23.

What is the 52 week high and 52 week low for Vogenx, Inc. share?

Vogenx, Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Vogenx, Inc. stock price today i.e. is trending at $19.71,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Vogenx, Inc.'s market capitalisation today?

Vogenx, Inc. market capitalisation is $0.00T as on .

How to invest in Vogenx, Inc. Stock (VOGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vogenx, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vogenx, Inc. Stock (VOGX) from India?

Indian investors can start investing in Vogenx, Inc. (VOGX) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Vogenx, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Vogenx, Inc. share’s latest price of $19.71 as on October 30, 2026 at 9:49 pm IST, you will get 0.5074 shares of Vogenx, Inc.. Learn more about fractional shares .